Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30073903HIVENSG00000185010.15protein_codingF8NoNo2157P00451
TVIS30073904HIVENSG00000185010.15protein_codingF8NoNo2157P00451
TVIS30073905HIVENSG00000185010.15protein_codingF8NoNo2157P00451
TVIS30073906HIVENSG00000185010.15protein_codingF8NoNo2157P00451
TVIS20011817HPVENSG00000185010.15protein_codingF8NoNo2157P00451
TVIS44000457HTLV-1ENSG00000185010.15protein_codingF8NoNo2157P00451
TVIS44051779HTLV-1ENSG00000185010.15protein_codingF8NoNo2157P00451
TCGA Plot Options
Drug Information
GeneF8
DrugBank IDDB00055
Drug NameDrotrecogin alfa
Target IDBE0000016
UniProt IDP00451
Regulation Typeinhibitor
PubMed IDs9184404; 18954704; 11752352; 6419799
CitationsGeng JP, Castellino FJ: Properties of a recombinant chimeric protein in which the gamma-carboxyglutamic acid and helical stack domains of human anticoagulant protein C are replaced by those of human coagulation factor VII. Thromb Haemost. 1997 May;77(5):926-33.@@Colin G, Annane D: Corticosteroids and human recombinant activated protein C for septic shock. Clin Chest Med. 2008 Dec;29(4):705-12, x. doi: 10.1016/j.ccm.2008.06.009.@@Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.@@Fulcher CA, Gardiner JE, Griffin JH, Zimmerman TS: Proteolytic inactivation of human factor VIII procoagulant protein by activated human protein C and its analogy with factor V. Blood. 1984 Feb;63(2):486-9.
GroupsApproved; Investigational; Withdrawn
Direct ClassificationPeptides
SMILES
Pathways
PharmGKBPA131548935
ChEMBL